Drug Profile
ANZ 521
Alternative Names: ANZ-521; Hepatitis C vaccine - Chinook TherapeuticsLatest Information Update: 18 Aug 2023
Price :
$50
*
At a glance
- Originator Cerus Corporation
- Developer Chinook Therapeutics
- Class Viral hepatitis vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Hepatitis C